• 医学文献
  • 知识库
  • 评价分析
  • 全部
  • 中外期刊
  • 学位
  • 会议
  • 专利
  • 成果
  • 标准
  • 法规
  • 临床诊疗知识库
  • 中医药知识库
  • 机构
  • 作者
热搜词:
换一批
论文 期刊
取消
高级检索

检索历史 清除

医学文献 >>
  • 全部
  • 中外期刊
  • 学位
  • 会议
  • 专利
  • 成果
  • 标准
  • 法规
知识库 >>
  • 临床诊疗知识库
  • 中医药知识库
评价分析 >>
  • 机构
  • 作者
热搜词:
换一批

氧气驱动雾化吸入在支气管哮喘急性发作救治中的效果分析

Analysis of the effect of oxygen driven aerosol inhalation in the treatment of acute exacerbation of bronchial asthma

摘要:

目的 观察氧气驱动雾化吸入在支气管哮喘急性发作救治中的临床效果.方法 选取96例支气管哮喘急性发作患者作为研究对象,采用随机数字表法分为观察组和对照组,各48例.两组患者均采用沙丁胺醇和布地奈德雾化吸入治疗,其中对照组患者采用超声雾化吸入法,观察组患者采用氧气驱动雾化吸入法.观察两组治疗前后的血氧饱和度(SpO2)、最大呼气峰流速(PEF)、第1秒用力呼气容量(FEV1)和呼吸指数(RI),比较主要临床症状消失时间,分析其临床效果.结果 治疗后,观察组的总有效率91.67%,对照组的总有效率为72.92%,组间差异有统计学意义(χ2=7.19,P<0.05).与对照组相比,观察组的发热、咳嗽、气喘、哮鸣音、肺部啰音及气短等主要临床症状消失时间均明显缩短[观察组:(3.05±1.23)d、(4.43±1.16)d、(3.12±1.11)d、(4.26±1.37)d、(4.98±1.75)d、(3.51±1.37)d,对照组:(4.14±1.03)d、(7.75±1.98)d、(5.75±1.86)d、(6.53±1.46)d、(8.42±1.55)d、(6.53±1.46)d],差异均有统计学意义(t=4.71、10.02、8.41、7.86、10.20、10.45,均P<0.01).治疗后,两组SpO2、PEF、FEV1均明显升高[观察组:(98.70±1.44)%、(126.33±9.87)mL/min、(2.06±0.52)L;对照组:(83.15±1.39)%、(108.32±7.26)mL/min、(1.42±0.38)L],而RI显著下降(观察组:0.17±0.08,对照组:0.27±0.06),两组差异均有统计学意义(t观=36.18、16.77、12.04、10.69,t对=11.03、8.15、5.34、2.69,均P<0.01),且观察组的SpO2、PEF、FEV1及RI改善程度明显优于对照组(t=53.83、10.18、6.88、6.74,均P<0.01).结论 在救治支气管哮喘急性发作中,采用氧气驱动雾化吸入治疗临床疗效显著,可有效地缓解患者发热、咳嗽等主要的临床症状,改善肺通气功能,值得临床进一步推广应用.

更多
abstracts:

Objective To analyze the effect of oxygen driven aerosol inhalation in the treatment of acute exacerbation of bronchial asthma .Methods 96 patients with acute exacerbation of bronchial asthmawere selected as the subjects .They were divided into observation group and control group by the random number table ,48 cases in each group.All patients were treated with salbutamol and budesonide inhalation therapy ,the control group was treated with ultrasonic atomization inhalation ,the observation group was treated with oxygen driven aerosol inhalation .The changes of blood oxygen saturation ( SpO2 ) ,maximum expiratory peak flow ( PEF) ,forced expiratory volume in the first second ( FEV1 ) and respiratory index ( RI) were observed before and after treatment in the two groups .The time of disappear-ance of major clinical symptoms was compared ,and the clinical treatment effect was analyzed .Results After treat-ment,the total effective rate of the observation group was 91.67%,which of the control group was 72.92%,the differ-ence between the two groups was statistically significant (χ2 =7.19,P<0.05).Compared with the control group ,the fever,cough,asthma,wheezing,shortness of breath,pulmonary rales and main clinical symptoms disappear time of the observation group were significantly shortened [observation group:(3.05 ±1.23)d,(4.43 ±1.16)d,(3.12 ± 1.11)d,(4.26 ±1.37)d,(4.98 ±1.75)d,(3.51 ±1.37)d;control group:(4.14 ±1.03)d,(7.75 ±1.98)d, (5.75 ±1.86)d,(6.53 ±1.46)d,(8.42 ±1.55)d,(6.53 ±1.46)d,t=4.71,10.02,8.41,7.86,10.20,10.45, all P<0.01].After treatment,the SpO2,PEF and FEV1 of the two groups were significantly increased [observation group:( 98.70 ±1.44 )%, ( 126.33 ±9.87 ) mL/min, ( 2.06 ±0.52 ) L;control group:( 83.15 ±1.39 )%,(108.32 ±7.26)mL/min,(1.42 ±0.38)L],while RI decreased significantly[observation group:(0.17 ±0.08), control group:(0.27 ±0.06),the differences were significant (to =36.18,16.77,12.04,10.69,tc =11.03,8.15, 5.34,2.69,all P<0.01),and the improvement of SpO2,PEF,FEV1 and RI of the observation group were significantly better than those of the control group (t=53.8310.18,6.88,6.74,all P<0.01).Conclusion In the treatment of acute exacerbation of bronchial asthma ,the clinical efficacy of oxygen driven aerosol inhalation is significant .The way can better alleviate patients'major clinical symptoms,such as fever,cough,improve lung ventilation function,and is worthy of further clinical application .

More
作者: 沈剑杰 [1] 曹冬敏 [1]
期刊: 《中国基层医药》2018年25卷8期 1014-1018页 ISTIC
栏目名称: 论著
DOI: 10.3760/cma.j.issn.1008-6706.2018.08.017
发布时间: 2018-04-27
  • 浏览:122
  • 下载:28

加载中!

相似文献

  • 中文期刊
  • 外文期刊
  • 学位论文
  • 会议论文

加载中!

加载中!

加载中!

加载中!

扩展文献

特别提示:本网站仅提供医学学术资源服务,不销售任何药品和器械,有关药品和器械的销售信息,请查阅其他网站。

  • 客服热线:4000-115-888 转3 (周一至周五:8:00至17:00)

  • |
  • 客服邮箱:yiyao@wanfangdata.com.cn

  • 违法和不良信息举报电话:4000-115-888,举报邮箱:problem@wanfangdata.com.cn,举报专区

官方微信
万方医学小程序
new翻译 充值 订阅 收藏 移动端

官方微信

万方医学小程序

使用
帮助
Alternate Text
调查问卷